CELU’s price-to-sales ratio: Is it a good investment opportunity?

Celularity Inc (CELU)’s stock has witnessed a price hike of 4.92% from the previous close with its current price standing at $2.35. Its current price is -54.98% under its 52-week high of $5.22 and 134.85% more than its 52-week low of $1.00. Based on the past 30-day period, the stock price is -4.65% below the high and +37.34% above the low.

The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, CELU’s SMA-200 is $2.06.

Additionally, it is important to take into account CELU stock ratios, including its price-to-sales ratio, which is 1.04 for the last tewlve months.CELU’s price to book ratio for the most recent quarter was 6.00, resulting in an 76.06 price to cash per share for the period.

How does Celularity Inc (CELU) stock rate among analysts? Buy, sell, or hold?

The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 0 brokerage firms that recommend the stock as a Strong Sell. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 0.00 in simple terms.

Celularity Inc (NASDAQ: CELU) Ownership Details

I will give a breakdown of the key shareholders in Celularity Inc (CELU). Recent figures show that the company’s insiders hold 51.26% of shares. A total of 36 institutional investors hold shares in the company, making 14.66% of its stock and 30.07% of its float.

Mar 31, 2025 , it was reported that the Company’s largest institutional holder is C V STARR & CO INC holding total of 764.07 shares that make 3.19% of the company’s total number of shares and are currently priced at 1.88 million.

The securities firm Vanguard Group Inc holds 500.13 shares of CELU, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 2.09% , and the holding percentage of shares is valued at 1.23 million.

An overview of Celularity Inc’s technicals

In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Celularity Inc (CELU) traded 404,183 shares per day, with a moving average of $1.97 and price change of +0.61. With the moving average of $1.98 and a price change of +0.79, about 213,193 shares changed hands on average over the past 50 days. Finally, CELU’s 100-day average volume is 170,937 shares, alongside a moving average of $1.77 and a price change of +0.48.

Hot this week

Right Now, Here’s How You Can Trade CRISPR Therapeutics AG (CRSP) Aggressively

Currently, CRISPR Therapeutics AG's (CRSP) stock is trading at...

The VNET Group Inc ADR (VNET) Stock Is Headed for a Correction

In the current trading session, VNET Group Inc ADR's...

Choosing between riding the trend or protecting profits: Cogent Biosciences Inc (COGT)

Cogent Biosciences Inc (COGT)'s stock is trading at $10.95...

Our Attention Has Been Attracted to Glimpse Group Inc (NASDAQ:VRAR)

Glimpse Group Inc (VRAR)'s stock has witnessed a price...

Observations on the Teladoc Health Inc (NYSE:TDOC) Growth Curve

Currently, Teladoc Health Inc's (TDOC) stock is trading at...

Topics

Right Now, Here’s How You Can Trade CRISPR Therapeutics AG (CRSP) Aggressively

Currently, CRISPR Therapeutics AG's (CRSP) stock is trading at...

The VNET Group Inc ADR (VNET) Stock Is Headed for a Correction

In the current trading session, VNET Group Inc ADR's...

Choosing between riding the trend or protecting profits: Cogent Biosciences Inc (COGT)

Cogent Biosciences Inc (COGT)'s stock is trading at $10.95...

Our Attention Has Been Attracted to Glimpse Group Inc (NASDAQ:VRAR)

Glimpse Group Inc (VRAR)'s stock has witnessed a price...

Observations on the Teladoc Health Inc (NYSE:TDOC) Growth Curve

Currently, Teladoc Health Inc's (TDOC) stock is trading at...

What Are the Chances of Atyr Pharma Inc (ATYR) Stagnating? Here is the INSIGHT

Atyr Pharma Inc (ATYR)'s stock is trading at $5.59...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.